Influence of Dietary Zinc, Copper and Cadmium Levels on Rat Liver Aryl Sulfotransferase IV Activity

  • Chung Keun Hee (Department of Food and Nutrition, Sahmyook University) ;
  • Ringel David P. (American Cancer Society) ;
  • Shin Kyung Ok (Department of Food and Nutrition, Sahmyook University)
  • Published : 2006.02.01

Abstract

Aryl sulfotransferase (AST) IV is a liver enzyme involved in detoxication and has been shown to be susceptible to down regulation by a number of hepatotoxic xenobiotics. Studies presented here to investigate the ability of biological and non-biological divalent metal cations on AST IV activity showed that AST IV was strongly inhibited following in vitro or in vivo exposure to. Zn ( II ), Co ( II ) or Cd ( II ). It was found that $0.025\sim$2.5 uM of these metal ions were sufficient to cause $50\%$ of inhibition in vitro in purified AST IV and $0.25\sim$25 uM of these metal ions in liver cytosolic fractions. For the in vivo study, 1,000 mg Cu ( II )/kg, 2,000 mg Zn ( II )/kg or 250 mg Cd( II )/kg was added to individual diets and administered to three (3) group; of mts over a 7 week period The Co ( II )-supplemented diet produced no apparent change in rat growth rate and resulted in 30-fold increase in liver cytotolic Cu ( II ) levels, suggesting that elevated levels of Cu ( II ) ion in the liver were responsible for the loss of AST IV activity. In contrast, the Zn ( II )-supplemented diet caused a decrease in rat growth rates and resulted in zero increase in liver Zn ( II ) levels, which suggested an indirect inhibition mechanism was caused by Zn ( II ) in the liver. Rats were fed the Cd-supplemented diet also displayed a decrease in growth rate with little or no change in liver Cu ( II ) or Zn ( II ) levels. When the liver cytosols of mts from the metal ion diets were immunochemically analyzed for the AST IV and albumin contents, no significant changes were observed in albumin levels. However, AST IV contents in the cytosols of mts fed the Zn ( II )-supplemented diets showed a slight decrease in amount These results showed that AST IV activity in vitro and in vivo can be inhibited by Co ( II ), Zn ( II ), and Cd ( II ) by apparently different mechanisms. The immediate response to a Zn injection showed a decrease in AST IV activity but not in the AST IV content in liver cytosol. These mechanisms appeared to involve direct actions of the metal ion on AST IV activity and indirect actions affecting AST IV amount.

Keywords

References

  1. Blanck A, Wicksell L, Eriksson LC. Sulfation of N-hydroxy-2-acetylaminofluene in normal and modular liver from male Wistar rats. Toxicol Pathol 15:103-105, 1987 https://doi.org/10.1177/019262338701500115
  2. Debaum JR, Miller EC, Miller JA. N-hydroxy-2-acetylaminofluorene sulfotransferase:its probable role in carcinogenesis and ptrtein-(methion-S-yl)-binding in rat liver. Cancer Res 30:577-595, 1970
  3. Debaum JR, Rowley JY, Miller FC, Miller JA. Sulfotransferase activation of N-hydroxy-2-acetylamino-fluorene in rodents liver susceptible and resistant to this carsinogen. Proc Soc Exp Biol Med 129:268-273, 1968 https://doi.org/10.3181/00379727-129-33301
  4. Irving CC. Comparative toxicity of N-hydroxy-2-acetylaminofluorene in several strain of rats. Cancer Res 35:2959-2961, 1975
  5. King CM, Phillips B. Enzyme-catalized reactions of the carcinogen N-hydroxy-2-flutoenylavetamide with nucleic acid. Science 159:1351-1353, 1968 https://doi.org/10.1126/science.159.3821.1351
  6. Lai C-C, Miller JA, Miller EC, Liem A. N-Sulfooxy-2-aminoflurene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetyl-aminoflurene in the livers of infant male C5BL/6J*C3H/HeJF1 (BGC3F1)mice. Carcinogenesis 6:1037-1045, 1985 https://doi.org/10.1093/carcin/6.7.1037
  7. Meerman JHN, Mulder GJ. Prevention of the hepatoxic action of N-hydroxy-2-acetylaminofluorene in the rats by inhibition of N-O-sulfation by pentachlorophenol. Life Sci 28:2361-2365, 1981 https://doi.org/10.1016/0024-3205(81)90501-4
  8. Mulder GI, Meerman JHN. Sulfation and gluconidation as competing pathways in the metabolism of hydroxamiv acids:the role of N, O-sulfonation in chemical carcinogensis of aromatic amines. Environ Health Perspect 49:27-32, 1983 https://doi.org/10.2307/3429577
  9. Meerman JHN, van Doom ABD, Muller GJ. Inhibition of sulfate conjugation of N-hydroxy-2-acetyl-aminofluorene in isolated perfused rat liver and in the rat in vivo by pentachlorophenol and low sulfate. Cancer Res 40:3772-3779, 1980
  10. Weisberger JH, Yamamoto RS, Williams GM, Gramtham PH, Matsushima T, Weisburger EK. On the sulfate ester of N-hydroxy-N-fluorenylacetamide as key ultimate hepacarcinogen in the rat. Cancer Res 32:491-500, 1972
  11. Yamamoto RS, Glass RM, Frankel HH, Weisburger EK, Weisburger JH. Inhibition of the toxicity and carcinogenicity of N-2-fluorenylacetamide by acetamide. Toxicol Appl Pharmacol 13:108-117, 1968 https://doi.org/10.1016/0041-008X(68)90139-7
  12. Rigner DP, Kampschmidt K, Jing RL, Jackson S, Kizer DE. Rapid decrease in N-hydroxy-2-acetylaminolfuorene sulfotrans-ferase activity of liver cytosols from rats fed carcinogen. Biochem Pharmacol 32:315-319. 1983 https://doi.org/10.1016/0006-2952(83)90561-0
  13. Rigner DP, Norton TR. Further characterization of the ability of hepatocarcinogens to lower rat liver aryl sulfotransferase activity. Carcinogenesis 8: 1749-1752, 1987 https://doi.org/10.1093/carcin/8.11.1749
  14. Ringer DP, Norton TR, Kizer DE. Effect of sulfotranferase inhibitors on the 2-acetylaminofluotene-mediated lowering of rat liver N-hydroxy-2-acetylarninofluorene sulfotransferase activity. Biochem Pharmacal 34: 3383-3386, 1985 https://doi.org/10.1016/0006-2952(85)90363-6
  15. Wu SG, Straub KD. Purficiation and characterization of N-hydroxy-2-acetylaminofluorene sulfotransferase from rat liver. J Biol Chem 251:6529-6536, 1976
  16. Underwood EJ. Trace elements in human and animal nutrition. pp.95, Academic Press, New York, 1977
  17. Bremmer I, Hoekstra WG, Davis NT, Young BW. Effect of zinc status of rats on the synthesis and degration of copper-induced metallothioneins. Biochem J 174:883-892, 1978 https://doi.org/10.1042/bj1740883
  18. Rucker R, Tinker D. The role of Nutrition in gene expression: A fertile field for the application of molecular biology. J Nutr 116:177-189, 1986 https://doi.org/10.1093/jn/116.2.177
  19. Smith SE, Larson EJ. Zinc toxicity in rats and antagonistic effects of copper and silver. J Biol Chem 163:294-298, 1946
  20. Van Reen R. Effects of excessive dietary zinc in the rat and the interrelationship with copper. Arch Biochem Biophys 46:337-342, 1953 https://doi.org/10.1016/0003-9861(53)90206-9
  21. Hill CH, Starch B, Payne WL, Babrer CW. in vivo interactions of cadmium with copper, zinc, and iron. J Nutr 80:227-235, 1963 https://doi.org/10.1093/jn/80.3.227
  22. Powell SD, Miller G, Morton JD, Clifton CM. Influence of dietary cadmium level and supplemental zinc on cadmium toxicity in bovine. J Nutr 84:205-214, 1960 https://doi.org/10.1079/096582197388554
  23. Matrone G, Hartman RH, Clawson AJ. Studies of manganese-iron antagonism in the nutrition of rabbits and baby pigs. J Nutr 67:309-317, 1959 https://doi.org/10.1093/jn/67.2.309
  24. Supplee WC. Production of zinc deficiency in turkey poults by dietary cadmium. Poult Sci 40:827-828, 1961 https://doi.org/10.3382/ps.0400827
  25. Hill CH. Reversal of selenium toxicity in chicks by mercury, copper and cadmium. J Nutr 104:593-598, 1974 https://doi.org/10.1093/jn/104.5.593
  26. Peterson RP, Jensen LS. Interrelationships of dietary silver with copperin the chick. Poult Sci 54:771-775, 1975 https://doi.org/10.3382/ps.0540771
  27. Sheroeder HA, Mitchener M, Nason AP. Life-term effects of nickel in rats:Survival, tumors. Interaction with trace elements and tissue levels. J Nutr 104:239-243, 1974 https://doi.org/10.1093/jn/104.2.239
  28. Thomson A, Hansard SL, Bell MC. The influence of aluminumand zinc upon the absorption and retention of calcium and phosphorus in lambs. J Anim Sci 18:187-192, 1959 https://doi.org/10.2527/jas1959.181187x
  29. Van Compen DR. Copper interference with the interstinal absorption of zinc by rats. J Nutr 97: 104-108, 1970 https://doi.org/10.1017/S0007114507205781
  30. Ringer DP, Norton TR, Boyd HW. 2-Acetylaminofluorene-mediated alterationin the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis. Cancer Res 50:5301-5307, 1990
  31. Lowery OH, Rosebrough NJ, Farr AL, Randall RJ. Protein determination with the folin phenol reagent. J Biol Chem 193:265-275, 1951
  32. Sekura RD, Jakoby WB. Aryl Sulfotransferase IV from rat liver. Arch Biochem Biophys 211:352-359, 1981 https://doi.org/10.1016/0003-9861(81)90464-1
  33. Karmen A. A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest 34(1):131-133, 1955
  34. Chung K, Romero N, Tinker D, Leen C, Amemiya K, Rucker R. Role of copper in the regulation and accumulation of superoxide dismutase and metallothionein in rat liver. J Nutr 118:859-864, 1988 https://doi.org/10.1093/jn/118.7.859